3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Myelodysplastic Syndromes
14
Hodgkin Disease
10
Hematologic Neoplasms
10
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
9
Leukemia
8
Lymphoma, Non-Hodgkin
7
Myeloproliferative Disorders
6
Multiple Myeloma
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Graft vs Host Disease
6
Waldenstrom Macroglobulinemia
5
Lymphoma
5
Leukemia, Myelomonocytic, Chronic
5
Lymphoma, Mantle-Cell
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia, Biphenotypic, Acute
4
Anemia, Refractory, with Excess of Blasts
4
Primary Myelofibrosis
3
Myelodysplastic-Myeloproliferative Diseases
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Prolymphocytic
3
Congenital Abnormalities
3
Blast Crisis
3
Anemia, Aplastic
3
Thrombocythemia, Essential
2
Sezary Syndrome
2
Recurrence
2
Interventions
Nivolumab
2
Ipilimumab
2
spartalizumab
1
poly ICLC
1
balstilimab
1
atezolizumab
1
Specimen Handling
1
Sorafenib
1
Irinotecan
1
DT2216
1
Cyclophosphamide
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fibrolamellar hepatocellular carcinoma
×
Mycophenolic Acid
×
90 days
×
Clear all
No trials found.